ID NAGZ_BACSU Reviewed; 642 AA. AC P40406; DT 01-FEB-1995, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1995, sequence version 1. DT 27-MAR-2024, entry version 148. DE RecName: Full=Beta-hexosaminidase; DE EC=3.2.1.52 {ECO:0000269|PubMed:20400549, ECO:0000269|PubMed:20826810}; DE AltName: Full=Beta-N-acetylhexosaminidase; DE AltName: Full=N-acetyl-beta-glucosaminidase; DE AltName: Full=N-acetylglucosaminidase; DE AltName: Full=ORF1; DE Flags: Precursor; GN Name=nagZ; Synonyms=ybbD, yzbA; OrderedLocusNames=BSU01660; OS Bacillus subtilis (strain 168). OC Bacteria; Bacillota; Bacilli; Bacillales; Bacillaceae; Bacillus. OX NCBI_TaxID=224308; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=BD99 / MS94; RX PubMed=8011666; DOI=10.1016/0005-2728(94)90131-7; RA Quirk P.G., Guffanti A.A., Clejan S., Cheng J., Krulwich T.A.; RT "Isolation of Tn917 insertional mutants of Bacillus subtilis that are RT resistant to the protonophore carbonyl cyanide m-chlorophenylhydrazone."; RL Biochim. Biophys. Acta 1186:27-34(1994). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=168; RX PubMed=9274029; DOI=10.1099/00221287-143-8-2763; RA Liu H., Haga K., Yasumoto K., Ohashi Y., Yoshikawa H., Takahashi H.; RT "Sequence and analysis of a 31 kb segment of the Bacillus subtilis RT chromosome in the area of the rrnH and rrnG operons."; RL Microbiology 143:2763-2767(1997). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=168; RX PubMed=9384377; DOI=10.1038/36786; RA Kunst F., Ogasawara N., Moszer I., Albertini A.M., Alloni G., Azevedo V., RA Bertero M.G., Bessieres P., Bolotin A., Borchert S., Borriss R., RA Boursier L., Brans A., Braun M., Brignell S.C., Bron S., Brouillet S., RA Bruschi C.V., Caldwell B., Capuano V., Carter N.M., Choi S.-K., RA Codani J.-J., Connerton I.F., Cummings N.J., Daniel R.A., Denizot F., RA Devine K.M., Duesterhoeft A., Ehrlich S.D., Emmerson P.T., Entian K.-D., RA Errington J., Fabret C., Ferrari E., Foulger D., Fritz C., Fujita M., RA Fujita Y., Fuma S., Galizzi A., Galleron N., Ghim S.-Y., Glaser P., RA Goffeau A., Golightly E.J., Grandi G., Guiseppi G., Guy B.J., Haga K., RA Haiech J., Harwood C.R., Henaut A., Hilbert H., Holsappel S., Hosono S., RA Hullo M.-F., Itaya M., Jones L.-M., Joris B., Karamata D., Kasahara Y., RA Klaerr-Blanchard M., Klein C., Kobayashi Y., Koetter P., Koningstein G., RA Krogh S., Kumano M., Kurita K., Lapidus A., Lardinois S., Lauber J., RA Lazarevic V., Lee S.-M., Levine A., Liu H., Masuda S., Mauel C., RA Medigue C., Medina N., Mellado R.P., Mizuno M., Moestl D., Nakai S., RA Noback M., Noone D., O'Reilly M., Ogawa K., Ogiwara A., Oudega B., RA Park S.-H., Parro V., Pohl T.M., Portetelle D., Porwollik S., RA Prescott A.M., Presecan E., Pujic P., Purnelle B., Rapoport G., Rey M., RA Reynolds S., Rieger M., Rivolta C., Rocha E., Roche B., Rose M., Sadaie Y., RA Sato T., Scanlan E., Schleich S., Schroeter R., Scoffone F., Sekiguchi J., RA Sekowska A., Seror S.J., Serror P., Shin B.-S., Soldo B., Sorokin A., RA Tacconi E., Takagi T., Takahashi H., Takemaru K., Takeuchi M., RA Tamakoshi A., Tanaka T., Terpstra P., Tognoni A., Tosato V., Uchiyama S., RA Vandenbol M., Vannier F., Vassarotti A., Viari A., Wambutt R., Wedler E., RA Wedler H., Weitzenegger T., Winters P., Wipat A., Yamamoto H., Yamane K., RA Yasumoto K., Yata K., Yoshida K., Yoshikawa H.-F., Zumstein E., RA Yoshikawa H., Danchin A.; RT "The complete genome sequence of the Gram-positive bacterium Bacillus RT subtilis."; RL Nature 390:249-256(1997). RN [4] RP FUNCTION, CATALYTIC ACTIVITY, INDUCTION, AND SUBCELLULAR LOCATION. RC STRAIN=168; RX PubMed=20400549; DOI=10.1128/jb.01256-09; RA Litzinger S., Duckworth A., Nitzsche K., Risinger C., Wittmann V., RA Mayer C.; RT "Muropeptide rescue in Bacillus subtilis involves sequential hydrolysis by RT beta-N-acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase."; RL J. Bacteriol. 192:3132-3143(2010). RN [5] {ECO:0007744|PDB:3BMX, ECO:0007744|PDB:3NVD} RP X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) IN COMPLEX WITH TRANSITION STATE RP ANALOG, CATALYTIC ACTIVITY, FUNCTION, MUTAGENESIS OF ASP-232 AND HIS-234, RP ACTIVE SITE, AND BIOPHYSICOCHEMICAL PROPERTIES. RC STRAIN=168; RX PubMed=20826810; DOI=10.1074/jbc.m110.131037; RA Litzinger S., Fischer S., Polzer P., Diederichs K., Welte W., Mayer C.; RT "Structural and kinetic analysis of Bacillus subtilis N- RT acetylglucosaminidase reveals a unique Asp-His dyad mechanism."; RL J. Biol. Chem. 285:35675-35684(2010). RN [6] {ECO:0007744|PDB:4GYJ, ECO:0007744|PDB:4GYK} RP X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 18-642 IN COMPLEX WITH SUBSTRATE RP ANALOGS, ACTIVE SITE, AND MUTAGENESIS OF ASP-318. RX PubMed=23177201; DOI=10.1016/j.chembiol.2012.09.016; RA Bacik J.P., Whitworth G.E., Stubbs K.A., Vocadlo D.J., Mark B.L.; RT "Active site plasticity within the glycoside hydrolase NagZ underlies a RT dynamic mechanism of substrate distortion."; RL Chem. Biol. 19:1471-1482(2012). CC -!- FUNCTION: Plays a role in peptidoglycan recycling by cleaving the CC terminal beta-1,4-linked N-acetylglucosamine (GlcNAc) from peptide- CC linked peptidoglycan fragments, giving rise to free GlcNAc, anhydro-N- CC acetylmuramic acid and anhydro-N-acetylmuramic acid-linked peptides. CC Cleaves muropeptides, but not peptidoglycan. CC {ECO:0000269|PubMed:20400549, ECO:0000269|PubMed:20826810}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Hydrolysis of terminal non-reducing N-acetyl-D-hexosamine CC residues in N-acetyl-beta-D-hexosaminides.; EC=3.2.1.52; CC Evidence={ECO:0000269|PubMed:20400549, ECO:0000269|PubMed:20826810}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC pH dependence: CC Optimum pH is 5.8-6.2. {ECO:0000269|PubMed:20826810}; CC -!- PATHWAY: Cell wall biogenesis; peptidoglycan recycling. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000255|PROSITE- CC ProRule:PRU00303}; Lipid-anchor {ECO:0000255|PROSITE-ProRule:PRU00303}. CC Secreted, cell wall {ECO:0000269|PubMed:20400549}. Note=Detected in the CC culture supernatant, predominantly associated with cell wall-derived CC particulate material. A minor proportion is detected in the soluble CC fraction. CC -!- INDUCTION: Up-regulated during the late phase of exponential growth and CC during stationary phase. {ECO:0000269|PubMed:20400549}. CC -!- SIMILARITY: Belongs to the glycosyl hydrolase 3 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L19954; AAA64351.1; -; Genomic_DNA. DR EMBL; AB002150; BAA19499.1; -; Genomic_DNA. DR EMBL; AL009126; CAB11942.1; -; Genomic_DNA. DR PIR; I39839; I39839. DR RefSeq; NP_388047.1; NC_000964.3. DR RefSeq; WP_003234975.1; NZ_JNCM01000030.1. DR PDB; 3BMX; X-ray; 1.40 A; A/B=1-642. DR PDB; 3LK6; X-ray; 2.88 A; A/B/C/D=27-642. DR PDB; 3NVD; X-ray; 1.70 A; A/B=1-642. DR PDB; 4GYJ; X-ray; 1.65 A; A/B=18-642. DR PDB; 4GYK; X-ray; 1.80 A; A/B=18-642. DR PDBsum; 3BMX; -. DR PDBsum; 3LK6; -. DR PDBsum; 3NVD; -. DR PDBsum; 4GYJ; -. DR PDBsum; 4GYK; -. DR AlphaFoldDB; P40406; -. DR SMR; P40406; -. DR STRING; 224308.BSU01660; -. DR DrugBank; DB08357; Diethylene glycol diethyl ether. DR CAZy; GH3; Glycoside Hydrolase Family 3. DR PaxDb; 224308-BSU01660; -. DR EnsemblBacteria; CAB11942; CAB11942; BSU_01660. DR GeneID; 938881; -. DR KEGG; bsu:BSU01660; -. DR PATRIC; fig|224308.179.peg.172; -. DR eggNOG; COG1472; Bacteria. DR InParanoid; P40406; -. DR OrthoDB; 9805821at2; -. DR PhylomeDB; P40406; -. DR BioCyc; BSUB:BSU01660-MONOMER; -. DR BRENDA; 3.2.1.52; 658. DR UniPathway; UPA00544; -. DR EvolutionaryTrace; P40406; -. DR Proteomes; UP000001570; Chromosome. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW. DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0004563; F:beta-N-acetylhexosaminidase activity; IEA:UniProtKB-EC. DR GO; GO:0102148; F:N-acetyl-beta-D-galactosaminidase activity; IEA:UniProtKB-EC. DR GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro. DR GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW. DR GO; GO:0009252; P:peptidoglycan biosynthetic process; IEA:UniProtKB-KW. DR GO; GO:0009254; P:peptidoglycan turnover; IBA:GO_Central. DR GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW. DR Gene3D; 3.40.50.1700; Glycoside hydrolase family 3 C-terminal domain; 1. DR Gene3D; 3.20.20.300; Glycoside hydrolase, family 3, N-terminal domain; 1. DR InterPro; IPR019800; Glyco_hydro_3_AS. DR InterPro; IPR002772; Glyco_hydro_3_C. DR InterPro; IPR036881; Glyco_hydro_3_C_sf. DR InterPro; IPR001764; Glyco_hydro_3_N. DR InterPro; IPR036962; Glyco_hydro_3_N_sf. DR InterPro; IPR017853; Glycoside_hydrolase_SF. DR PANTHER; PTHR30480:SF13; BETA-HEXOSAMINIDASE; 1. DR PANTHER; PTHR30480; BETA-HEXOSAMINIDASE-RELATED; 1. DR Pfam; PF00933; Glyco_hydro_3; 1. DR Pfam; PF01915; Glyco_hydro_3_C; 1. DR SUPFAM; SSF51445; (Trans)glycosidases; 1. DR SUPFAM; SSF52279; Beta-D-glucan exohydrolase, C-terminal domain; 1. DR PROSITE; PS00775; GLYCOSYL_HYDROL_F3; 1. DR PROSITE; PS51257; PROKAR_LIPOPROTEIN; 1. PE 1: Evidence at protein level; KW 3D-structure; Cell membrane; Cell shape; Cell wall; KW Cell wall biogenesis/degradation; Glycosidase; Hydrolase; Lipoprotein; KW Membrane; Palmitate; Peptidoglycan synthesis; Reference proteome; Secreted; KW Signal. FT SIGNAL 1..16 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00303" FT CHAIN 17..642 FT /note="Beta-hexosaminidase" FT /id="PRO_0000011785" FT ACT_SITE 234 FT /note="Proton donor/acceptor" FT /evidence="ECO:0000305|PubMed:20826810, FT ECO:0000305|PubMed:23177201" FT ACT_SITE 318 FT /note="Nucleophile" FT /evidence="ECO:0000305|PubMed:20826810, FT ECO:0000305|PubMed:23177201" FT BINDING 123 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:20826810, FT ECO:0000269|PubMed:23177201" FT BINDING 131 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:20826810, FT ECO:0000269|PubMed:23177201" FT BINDING 191 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:20826810, FT ECO:0000269|PubMed:23177201" FT BINDING 221..222 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:20826810, FT ECO:0000269|PubMed:23177201" FT SITE 232 FT /note="Important for catalytic activity" FT /evidence="ECO:0000305|PubMed:20826810" FT LIPID 17 FT /note="N-palmitoyl cysteine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00303" FT LIPID 17 FT /note="S-diacylglycerol cysteine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00303" FT MUTAGEN 232 FT /note="D->G: Strongly reduces catalytic efficiency and FT enzyme activity. Slightly increases substrate affinity." FT /evidence="ECO:0000269|PubMed:20826810" FT MUTAGEN 234 FT /note="H->G: Strongly reduces catalytic efficiency while FT increasing substrate affinity." FT /evidence="ECO:0000269|PubMed:20826810" FT MUTAGEN 318 FT /note="D->N: Abolishes enzyme activity." FT /evidence="ECO:0000269|PubMed:23177201" FT HELIX 27..40 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 44..50 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 57..59 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 75..84 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 87..90 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 93..95 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 99..112 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 114..116 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 119..122 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 133..135 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 141..147 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 150..167 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 186..188 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 189..191 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 197..213 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 217..223 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 226..228 FT /evidence="ECO:0007829|PDB:3LK6" FT STRAND 230..232 FT /evidence="ECO:0007829|PDB:3LK6" FT TURN 233..235 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 237..239 FT /evidence="ECO:0007829|PDB:3LK6" FT HELIX 244..249 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 252..260 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 265..268 FT /evidence="ECO:0007829|PDB:3BMX" FT TURN 274..276 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 280..282 FT /evidence="ECO:0007829|PDB:3BMX" FT TURN 284..286 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 289..291 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 294..296 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 298..301 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 302..308 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 313..316 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 323..326 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 331..341 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 344..348 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 355..358 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 359..373 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 379..395 FT /evidence="ECO:0007829|PDB:3BMX" FT TURN 396..401 FT /evidence="ECO:0007829|PDB:3NVD" FT HELIX 407..417 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 421..434 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 436..440 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 441..443 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 454..461 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 462..477 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 485..490 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 498..506 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 508..514 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 535..537 FT /evidence="ECO:0007829|PDB:4GYJ" FT HELIX 538..552 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 557..561 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 565..570 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 575..579 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 590..592 FT /evidence="ECO:0007829|PDB:3BMX" FT HELIX 595..603 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 620..622 FT /evidence="ECO:0007829|PDB:3BMX" FT STRAND 625..628 FT /evidence="ECO:0007829|PDB:3BMX" FT TURN 636..638 FT /evidence="ECO:0007829|PDB:3BMX" SQ SEQUENCE 642 AA; 70580 MW; DCEA93142922F13F CRC64; MRPVFPLILS AVLFLSCFFG ARQTEASASK RAIDANQIVN RMSLDEKLGQ MLMPDFRNWQ KEGESSPQAL TKMNDEVASL VKKYQFGGII LFAENVKTTK QTVQLTDDYQ KASPKIPLML SIDQEGGIVT RLGEGTNFPG NMALGAARSR INAYQTGSII GKELSALGIN TDFSPVVDIN NNPDNPVIGV RSFSSNRELT SRLGLYTMKG LQRQDIASAL KHFPGHGDTD VDSHYGLPLV SHGQERLREV ELYPFQKAID AGADMVMTAH VQFPAFDDTT YKSKLDGSDI LVPATLSKKV MTGLLRQEMG FNGVIVTDAL NMKAIADHFG QEEAVVMAVK AGVDIALMPA SVTSLKEEQK FARVIQALKE AVKNGDIPEQ QINNSVERII SLKIKRGMYP ARNSDSTKEK IAKAKKIVGS KQHLKAEKKL AEKAVTVLKN EQHTLPFKPK KGSRILIVAP YEEQTASIEQ TIHDLIKRKK IKPVSLSKMN FASQVFKTEH EKQVKEADYI ITGSYVVKND PVVNDGVIDD TISDSSKWAT VFPRAVMKAA LQHNKPFVLM SLRNPYDAAN FEEAKALIAV YGFKGYANGR YLQPNIPAGV MAIFGQAKPK GTLPVDIPSV TKPGNTLYPL GYGLNIKTGR PL //